SpaceX Re-Tests $150 IPO Price Level Amid Extreme Analyst Target Dispersion
Resolved · corporate · Occurred · Assessed · 1 sources
This assessment is dated 2026-09-15. Check what remains unresolved below before relying on it.
What does this change in the investment case for SpaceX?
High uncertainty in capital intensity for orbital constellation replenishment creates severe equity valuation bifurcation between cash flow and growth multiples.
| Question | What the evidence establishes |
|---|---|
| What was reported? | Reported factSpaceX shares have returned to their initial public offering level of approximately $150 following its June 2026 listing. |
| What else was confirmed? | Reported factAnalyst price targets on the stock span a wide distribution from $75 to $800, with a median target of $217. |
| Does the valuation support acting? | Interpretation5 stored valuation assumptions for SPCX; the latest is dated 2026-08-16. |
| What would change the assessment? | UnknownSPCX $150 technical support — Monitor trading volume and institutional bid depth at the $150 IPO issuance level. |
What would this event cost your holdings?
Apply your own hypothetical returns to current holding values. The calculator does not infer security effects from this event.
Test this event against my holdingsReported facts
- · SpaceX shares have returned to their initial public offering level of approximately $150 following its June 2026 listing.
- · Analyst price targets on the stock span a wide distribution from $75 to $800, with a median target of $217.
- · The company remains unprofitable on a net income basis while reporting revenue growth across launch and satellite internet operations.
Public research record
Research framework · page evidenceCompleted event assessment
cost of capital repricing on unprofitable growth valuation
| Type | Claim | Scope |
|---|---|---|
| Assumption | SpaceX shares have returned to their initial public offering level of approximately $150 following its June 2026 listing. | 2026-09-15 |
| Interpretation | cost of capital repricing on unprofitable growth valuation | SPCX |
Countercase, invalidators, and sources
Accelerating direct-to-cell enterprise contracts and launch cadence expansion drive re-rating toward the $217 median target.
- · SPCX $150 technical support — Monitor trading volume and institutional bid depth at the $150 IPO issuance level.
- SpaceX Is Trading Near Its Opening-Day Price Again · 2026-09-15
What remains unresolved
- Base path
- SPCX consolidates around the $150 IPO base pending next quarterly cash-burn and subscriber disclosures.
- Adverse path
- Sustained 5% Treasury yields compress unhedged duration multiples, pressuring shares toward the $75 bear case target.
- Supportive path
- Accelerating direct-to-cell enterprise contracts and launch cadence expansion drive re-rating toward the $217 median target.
- · SPCX $150 technical support — Monitor trading volume and institutional bid depth at the $150 IPO issuance level.today
Evidence
- SpaceX Is Trading Near Its Opening-Day Price Again2026-09-15
“SpaceX stock has returned to its opening-day price of ~$150 after a volatile ride since its June 2026 IPO. Analyst price targets range from $75 to $800, with a median target of $217.”
Supports: SpaceX shares trade near $150 with analyst price targets between $75 and $800.